About the Author
LINUS PAULING, Ph.D., won the Nobel Prize for Chemistry in 1954 and for Peace in 1962. EWAN CAMERON, M.B., Ch.B., F.R.C.S. (Edinburgh and Glasgow), was Medical Director of the Linus Pauling Institute of Science and Medicine.
- Cancer is a highly profitable business. It is about $$$$ and not curing people. There is no money to be made from Vitamin C which cannot be patented.
- Vitamin C Found to Halt Blood Cancer When Administered in High Doses… So Why Won’t the Cancer Industry Use It?
by Isabelle Z., http://www.naturalnews.com/
(Natural News) Early-stage trials have shown that high doses of vitamin C can help to fight blood cancer. While the cancer-fighting ability of this vitamin has long been known, the study shed some new light on its effects on leukemia.
Researchers at the Perlmutter Cancer Centercarried out a study using mice who had been engineered to be deficient in the TET2 enzyme, which is believed to protect against blood cancer and heart disease. They found that injecting high doses of vitamin C could stop leukemia cancer stem cells that had been implanted from humans into the mice from growing. Essentially, the researchers think that the vitamin tells faulty stem cells found in our bone marrow to die. In addition, they discovered that combining the vitamin with a type of drug known as a PARP inhibitor boosted its effects.
The study was published in the journal Cell, and the researchers suggest that vitamin C could be used to treat these types of cancer in conjunction with conventional treatments like chemotherapy in the future. They believe it could be particularly useful for patients who are not strong enough to undergo aggressive chemotherapy due to advanced age.
Vitamin C’s benefits for cancer patients discovered more than 40 years ago
It has been more than four decades since Nobel laureate Linus Pauling first demonstrated the effectiveness of a high dose of vitamin C– 10,000 mg daily – in reversing cancer. Many studies have since shown that it can indeed help patients with many types of cancer.
For example, it has been shown to reduce inflammation as well as tumor markers in patients with breast cancer and prostate cancer. In one study, 76 percent of cancer patients noted reduced inflammation levels after Vitamin C treatments, with the average patient’s CRP levels dropping by 80 percent. Those who had been given more IV vitamin C treatments noted better results.